Status | Study |
Completed |
Study Name: Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis Condition: Tinea Pedis Date: 2017-04-05 Interventions: Drug: Econazole Nitrate Cream, 1% Drug: Pl |
Recruiting |
Study Name: Three-Arm Trial of Novel Treatment for Tinea Pedis Condition: Tinea Pedis Date: 2016-12-20 Interventions: Drug: Experimental Drug SESC 01 |
Recruiting |
Study Name: Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot Condition: Tinea Pedis Date: 2016-08-04 Interventions: Drug: Nitric Oxide Delivered a |
Active, not recruiting |
Study Name: SB208 for the Treatment of Tinea Pedis Condition: Tinea Pedis Date: 2016-08-02 Interventions: Drug: SB208 2% SB208 2% once d |
Active, not recruiting |
Study Name: Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis Condition: Tinea Pedis Date: 2016-07-13 Interventions: Drug: S2G6T-1 Twice a day topi |
Completed |
Study Name: Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis Condition: Tinea Pedis Date: 2016-06-30 Interventions: Drug: Dapaconazole Drug: Ketoconazole |
Completed |
Study Name: Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris Condition: Tinea Pedis Tinea Cruris Date: 2016-05-03 Interventions: Drug: Luliconazole Cream 1% Luliconazole Other Name: |
Completed |
Study Name: Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% Condition: Foot Dermatoses Date: 2016-03-07 Interventions: Drug: Loceryl Nail Lacquer Top |
Completed |
Study Name: BE Study of Naftifine HCL Condition: Tinea Pedis Date: 2015-12-11 Interventions: Drug: Naftifine hydrochloride 2% |
Recruiting |
Study Name: Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis Condition: Foot Infection Tinea Pedis Date: 2015-11-26 Interventions: Drug: infected group Ginkgo Bi |